Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...
Co announces that Mylan Pharmaceuticals Inc. has received final approval from the FDA for its Abbreviated New Drug Applications for Ondansetron Hydrochloride Tablets, 4 mg, 8 mg and 24 mg, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback